NEW YORK (GenomeWeb) – BioNano Genomics said in a regulatory document that it raised $68.4 million in a financing round.
A spokesperson for the San Diego-based genomic mapping company told GenomeWeb that the amount includes a total of $53 million that BioNano raised in its Series C financing round. The funding will be used to expand the firm’s commercialization efforts, develop and launch a next-generation system, and establish BioNano’s diagnostics roadmap, “including readiness of a cytogenetics assay,” she said.
The company declined to name the investors, but in a document filed with the US Securities and Exchange Commission on Tuesday, it said that there were 17 participants in the financing round.
Help employers find you! Check out all the jobs and post your resume.
